Filter announcements
Loading...
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Solara Active Pharma Sciences received an Income Tax rectification order. A previously computed demand of Rs. 161.92 Cr has been dropped, eliminating this potential tax liability with no financial impact on the company.
SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication regarding the completion of dispatch of 9th AGM Notice and Annual report
Solara divested a subsidiary, a strategic portfolio adjustment. The company reported zero fines and achieved an 8.5% reduction in Scope 1 & 2 GHG emissions. Zero Liquid Discharge is implemented at 5 of 6 sites. However, worker safety incidents saw an uptick.
Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting ("AGM") of the Company scheduled to be held on Friday, September 18, 2026.
SOLARA: Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Newspaper Publication with respect to the Ninth Annual General Meeting.